The Effect of Gut Bacteria on the Brain

-
Context
In August 2012 stools gained the front cover of The Economist. The issue hosted a long article on the newly discovered relationships between stool bacteria (the gut microbiota – GMB) and the human host.
The GMB has recently been reconceptualised as yet another body organ, with an intense cross-talk with a number of other organs, including the brain. The mediators of the gut-brain cross-talk are circulating mediators, neural circuits and the immune-inflammatory system. Evidence is mounting that the GMB can affect normal human behavior and some psychiatric diseases such as autism. A pivotal role of the native GMB has been demonstrated in mouse models of multiple sclerosis and brain amyloidosis.
A role of the GMB in Alzheimer’s disease would account for so far unexplained findings such as the presence of circulating biomarkers and the protective effect of certain dietary regimens.

Aim
1. To inform physicians and scientists of the relevance and opportunities brought about by recent evidence on the role of the GMB in human brain diseases.
2. To promote the birth of a network of Swiss scientists to study the effect of the GMB in Alzheimer’s disease.
Lieu
Campus Biotech
Entrée
Gratuite
Organisateur(s)
Dernière mise à jour : 21/10/2020